Company Search:
Advanced Search
Sponsored Links
Global Blood Therapeutics Inc Company Snapshot
Global Blood Therapeutics Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Global Blood Therapeutics Inc with three other companies in this sector in UNITED STATES : Cara Therapeutics Inc (2020 sales of $135.08 million of which 100% was Discovery and development of novel thera), Cytomx Therapeutics Inc ($100.36 million of which 100% was oncology-focused biopharmaceutical), and Surface Oncology Inc ($126.16 million of which 100% was cancer therapies).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Global Blood Therapeutics Inc
  Stock Performance Chart for Global Blood Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (4/1/2021): 42.62
(Figures in U.S. Dollars)
1 Week 6.4%   13 Weeks 4.1%  
4 Weeks -1.6%   52 Weeks -19.1%  
Global Blood Therapeutics Inc Key Data:
  Ticker: GBT Country: United States
  Exchanges: NYSE Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 123,803,000
(Year Ending Jan 2021).
Employees: 389
  Currency: U.S. Dollars Market Cap: 2,638,096,596
  Fiscal Yr Ends: December Shares Outstanding: 61,898,090
  Share Type: Common Closely Held Shares: 6,949,434
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.